Immunogenic Cell Death (ICD)-Related Gene Signature Could Predict the Prognosis of Patients with Diffuse Large B-Cell Lymphoma

Ping, LQ; He, YX; Gao, Y; Wang, XX; Huang, C; Bai, B; Huang, HQ

Huang, HQ (通讯作者),Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Peoples R China.

JOURNAL OF PERSONALIZED MEDICINE, 2022; 12 (11):

Abstract

Background: Diffuse large B-cell lymphoma (DLBCL) is the most prevalent type of lymphoma that is potentially curable by chemotherapy. Immunogenic cell......

Full Text Link